Companion Diagnostics Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Companion Diagnostics Market is expected to reach USD 14,920.22 million by 2028, registering a CAGR of 20% during the forecast period 2022-2028. Companion diagnostics are medical devices used as in vitro diagnostic devices, which provide essential information about a drug or therapeutic product, such as whether the drug is safe and effective for a particular treatment in a patient, and to identify whether a patient is more likely. They benefit from prescription drugs and also do drug monitoring for their patients. Companion Diagnostic (CDx) is a clinical test co-developed with a therapeutic drug to screen responders and non-responders to a particular drug. It is done to identify a group of patients that can or cannot be treated with that drug. CDx helps ensure patient safety by helping doctors determine the benefits, side effects, and risks associated with taking medication.

Company Profile

The key players profiled in this report include Abbott Laboratories Molecular, Inc., Agilent (Dako Denmark A/S), ARUP Laboratories, Inc., BioMerieux SA, Danaher Corporation (Leica Microsystems), Foundation Medicine, Inc., Myriad Genetics, Inc., Qiagen N.V., Roche (Ventana Medical Systems, Inc.), and Thermo Fisher Scientific (Life Technologies Corporation). 

Market Segmentation

By Product & Service

• Assay kits & Reagents
• Software & Services

By Technology

• Polymerase Chain Reaction (PCR) 
• In Situ Hybridization (ISH) 
• Next-Generation Sequencing (NGS)
• Immunohistochemistry (IHC) 

By Indication

• Cardiovascular
• Neurological Diseases
• Cancer

Scope of the Report

The research study analyzes the Companion Diagnostics Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Companion Diagnostics Market Report

1. What was the Companion Diagnostics Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of Companion Diagnostics Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Companion Diagnostics Market was the market leader in 2021?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.